Green Valley Drugs Recalls L-Carnitine Injection Due to Sterility Concerns
Green Valley Drugs is recalling L-Carnitine Injection nationwide due to a lack of assurance of sterility in its compounding and quality control processes.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric, particularly given the risk of infection from non-sterile injectable products.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling L-Carnitine Injection, all strengths and presentations, including L-Carnitine 500 mg/mL 30 mL vials. The recall involves 65 vials distributed nationwide. Specific lots affected include Lot # 20130402-G (Exp 7/2/2013) and Lot # 20130129-H (Exp 4/29/2013).
The recall was initiated due to a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. The company cited concerns associated with its quality control processes as the reason for the action.
Consumers and healthcare providers should stop using the affected L-Carnitine Injection and contact their pharmacist or the recalling firm for instructions on how to return the product.
The recalled product
- Product
- L-Carnitine Injection, all strengths and all presentations including L-Carnitine 500 mg/mL 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable
- Affected units
- 65
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 20130402-G
- Exp 7/2/2013
- 20130129-H
- Exp 4/29/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereWells Pharmacy Recalls Carnitine-L Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereKRS Global Biotechnology Recalls L-Carnitine Vials Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereDowning Labs Recalls Acetyl-L-Carnitine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- HighL-Carnitine Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-09-21
- SevereAxia Pharmaceutical Recalls Levocarnitine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- HighL-Carnitine Injectable Injection Recalled for Sterility Concerns
FDA (Drugs) · 2021-11-17